Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: Assessment of hemostatic function under flow conditions

Transfusion

Volumn 47, Issue 4, 2007, Pages 666-671

  Lozano, Miguel ^a   Galan, Ana ^b   Mazzara, Roberto ^b   Corash, Laurence ^b   Escolar, Ginés ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN; THROMBOCYTE CONCENTRATE;

ARTICLE; EX VIVO STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE; PHOTOCHEMISTRY; STATISTICAL ANALYSIS; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE PRESERVATION; ULTRAVIOLET A RADIATION;

BLOOD PLATELETS; BLOOD PRESERVATION; HEMOSTASIS; HUMANS; LEUKOCYTE COUNT; PHOTOCHEMISTRY; PLATELET AGGREGATION; PLATELETPHERESIS; PSORALENS; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 33947405257     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01169.x     Document Type: Article

References (32)

1. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability - deleterious effect of refrigerated storage. N Engl J Med 1969;280:1094-8.
2. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell 2003;112:87-97.
3. Murphy S. What's so bad about old platelets? Transfusion 2002;42:809-11.
4. Esber E. Reduction of the maximum platelet storage period to 5 days in an approved container. FDA memorandum. Rockville (MD): U.S. Food and Drug Administration; 1986.
5. Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997;37:423-35.
6. Lin L, Hanson CV, Alter HJ, et al. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005;45:580-90.
7. Grass JA, Hei DJ, Metchette K, et al. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998;91:2180-8.
8. 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light. Transfusion 2004;44:1732-40.
9. Slichter SJ, Raife TJ, Davis K, et al. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia. Transfusion 2006;46:731-40.
10. van Rhenen D, Gulliksson H, Cazenave JP, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003;101:2426-33.
11. Janetzko K, Cazenave JP, Kluter H, et al. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion 2005;45:1443-52.
12. McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004;104:1534-41.
13. Simonsen AC, Johansson PI, Conlan MG, et al. Transfusion of 7-day-old amotosalen photochemically treated buffycoat platelets to patients with thrombocytopenia: a pilot study. Transfusion 2006;46:424-33.
14. Hernandez MR, Bozzo J, Mazzara R, et al. Platelet concentrates promote procoagulant activity: evidence from experimental studies using a perfusion technique. Transfusion 1995;35:660-5.
15. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973;5:167-79.
16. Escolar G, Bastida E, Ordinas A, et al. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination. Thromb Res 1985;40:419-24.
17. Escolar G, Mazzara R, Castillo R, et al. The role of the Baumgartner technique in transfusion medicine: research and clinical applications. Transfusion 1994;34:542-9.
18. Blajchman MA, Beckers EA, Dickmeiss E, et al. Bacterial detection of platelets: current problems and possible resolutions. Transfus Med Rev 2005;19:259-72.
19. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005;45:1845-52.
20. Benjamin RJ, Mintz PD. Bacterial detection and extended platelet storage: the next step forward. Transfusion 2005;45:1832-5.
21. Lin L, Dikeman R, Molini B, et al. Photochemical treatment of platelet concentrates with amotosalen and longwavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004;44:1496-504.
22. Van Voorhis WC, Barrett LK, Eastman RT, et al. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003;47:475-9.
23. Eastman RT, Barrett LK, Dupuis K, et al. Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation. Transfusion 2005;45:1459-63.
24. Heddle NM, Barty RL, Sigouin CS, et al. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days. Transfusion 2005;45:904-10.
25. van derMeer PF, Pietersz RN, Reesink HW. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality. Transfusion 2004;44:1204-11.
26. Dumont LJ, AuBuchon JP, Whitley P, et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002;42:847-54.
27. AuBuchon JP, Taylor H, Holme S, et al. In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers. Transfusion 2005;45:1356-61.
28. Escolar G, Garrido M, Mazzara R, et al. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion 1988;34:406-11.
29. Mazzara R, Escolar G, Garrido M, et al. Procoagulant effect of incompatible platelet transfusion in alloimmunized refractory patients. Vox Sang 1996;71:84-9.
30. Lozano M, Estebanell E, Cid J, et al. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage. Transfusion 1999;39:951-9.
31. Keuren JF, Cauwenberghs S, Heeremans J, et al. Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006;46:204-12.
32. Sakariassen KS, Ottenhof Rovers M, Sixma JJ. Factor VIIIvonWillebrand factor requires calcium for facilitation of platelet adherence. Blood 1984;63:996-103.